Retraction
Serum miR‑338‑5p has potential for use as a tumor marker for retinoblastoma
Paper Information
Record ID:
54045
Journal:
Publication Date:
May 07, 2019
Retraction Date:
March 19, 2024
(1.7 year years ago)
Subjects:
Institution:
Department of Ophthalmology, Peking University Third Hospital, Beijing 100191, P.R. ChinaCountry:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3892/ol.2024.14347Additional Notes:
see also: https://pubpeer.com/publications/18C0CFB3BC09B11DC189D72A64CD98
Citations (15)
15
Total Citations1
Post-Retraction(6.7%)
14
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
0
After 2+ years
408
Days since retraction (latest)
Comprehensive review and in silico analysis of the role of noncoding RNAs in retinoblastoma: A step-TowarRNA precision
Nadia Μ. Hamdy, Bassant Mohamed Barakat, Mona G El-Sisi et al. (10 authors)
International Journal of Biological Macromolecules
Published: May 2025
408 days after retraction
Advancements in the diagnosis, prognosis, and treatment of retinoblastoma
Shivam Rajput, Rishabha Malviya, Prerna Uniyal
Canadian Journal of Ophthalmology
Published: Feb 2024
3 citations
3 citations
33 days before retraction
Research Progress on Platinum Resistance Mechanism and Resistance Therapy in Retinoblastoma
应洁 罗
Advances in Clinical Medicine
Published: Jan 2024
78 days before retraction
miRNAs as potential game-changers in retinoblastoma: Future clinical and medicinal uses
Ahmed S. Doghish, Hebatallah Ahmed Mohamed Moustafa, Mohammed S. Elballal et al. (15 authors)
Pathology - Research and Practice
Published: May 2023
43 citations
43 citations
305 days before retraction
Expression level of serum <scp>miR</scp> ‐374a‐5p in patients with acute pancreatitis and its effect on viability, apoptosis, and inflammatory factors of pancreatic acinar cells induced by cerulein
Fujun Wang, Mei Xue
The Kaohsiung Journal of Medical Sciences
Open Access
Published: Mar 2023
3 citations
3 citations
372 days before retraction
Deciphering specific miRNAs in brain tumors: a 5-miRNA signature in glioblastoma
João Basso, Marco G. Paggi, Ana Fortuna et al. (5 authors)
Molecular Genetics and Genomics
Published: Feb 2022
12 citations
12 citations
761 days before retraction
The clinical diagnostic value of plasma miR-592 and miR-217-3p levels in retinoblastoma
Luo Yan, Lin Huang, Hu Yu et al. (7 authors)
Journal of Medical Biochemistry
Open Access
Published: Jan 2022
4 citations
4 citations
808 days before retraction
MicroRNA in Ophthalmology
Brovkina Af, G. A. Yarovaya, N. D. Tsybikova
Ophthalmology in Russia
Open Access
Published: Jul 2021
1 citation
1 citation
988 days before retraction
A minor review of microRNA-338 exploring the insights of its function in tumorigenesis
Qian Yi, Hanwei Cui, Yi Liao et al. (6 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: May 2021
4 citations
4 citations
1040 days before retraction
Plasma miR-6089 as potential diagnostic biomarker for retinoblastoma
Xiuhong Li, Anjie Shi, Jia Li et al. (4 authors)
International Ophthalmology
Published: Mar 2021
7 citations
7 citations
1088 days before retraction
LncRNA MBLN1-AS1 inhibits the progression of retinoblastoma through targeting miR-338-5p-Wnt/β-catenin signaling pathway
Lei Xu, Shenyu Zhu, Aidong Tang et al. (4 authors)
Inflammation Research
Published: Jan 2021
17 citations
17 citations
1158 days before retraction
<p>Effect of miR-515-5p on Proliferation and Drug Sensitivity of Retinoblastoma Cells</p>
Xiang Wen Yuan, Ting Yan, Huilin Tong
Cancer Management and Research
Open Access
Published: Nov 2020
20 citations
20 citations
1234 days before retraction
MicroRNA-338-5p alleviates neuronal apoptosis via directly targeting BCL2L11 in APP/PS1 mice
Junhua Li, Danhua Li, Huatao Zhou et al. (8 authors)
Aging
Open Access
Published: Oct 2020
29 citations
29 citations
1253 days before retraction
microRNA-144 functions as a diagnostic and prognostic marker for retinoblastoma
Qian Zheng, Qin Zhu, Cuiping Li et al. (8 authors)
Clinics
Open Access
Published: Jan 2020
13 citations
13 citations
1539 days before retraction
Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies
Barbara Pardini, Alexandru A. Sabo, Giovanni Birolo et al. (4 authors)
Cancers
Open Access
Published: Aug 2019
182 citations
182 citations
1679 days before retraction
Quick Stats
Total Citations:
15
Years Since Retraction:
1.7 year
Open Access:
Yes
Last Checked:
Jul 24, 2025